Chapter 5. Hormones and the Brain
Follow us on Facebook and Twitter, or subscribe to our mailing list, to receive news updates. Learn more.
By Laura Beil Kotex, the company that first capitalized on the concept of “feminine hygiene” more than 90 years ago, recently gained newfound success after it began targeting an underserved market: girls who start their periods before they start middle school. With hearts, swirls and sparkles, the U brand offers maxi pads and tampons for — OMG! — girls as young as 8, promoted through a neon-hued website with chatty girl-to-girl messages and breezy videos. “When I had my first period I was prepared,” reads one testimonial. “It was the summer before 4th grade….” Today it has become common for girls to enter puberty before discovering Are You There God? It’s Me, Margaret. Over the second half of the 20th century, the average age for girls to begin breast development has dropped by a year or more in the industrialized world. And the age of first menstruation, generally around 12, has advanced by a matter of months. Hispanic and black girls may be experiencing an age shift much more pronounced. The idea of an entire generation maturing faster once had a strong cadre of doubters. In fact, after one of the first studies to warn of earlier puberty in American girls was published in 1997, skeptics complained in the journal Pediatrics that “many of us in the field of pediatric endocrinology believe that it is premature to conclude that the normal age of puberty is occurring earlier.” Today, more than 15 years later, a majority of doctors appear to have come around to the idea. Have a conversation with a pediatric endocrinologist, and it isn’t long before you hear the phrase “new normal.” © Society for Science & the Public 2000 - 2012
By Melissa Healy, Los Angeles Times If retired Army Gen. David H. Petraeus had gotten an occasional dose of supplemental oxytocin, a brain chemical known to promote trust and bonding, he might still be director of the Central Intelligence Agency, new research suggests. A study published Tuesday in the Journal of Neuroscience has uncovered a surprising new property of oxytocin, finding that when men in monogamous relationships got a sniff of the stuff, they subsequently put a little extra space between themselves and an attractive woman they'd just met. Oxytocin didn't have the same effect on single heterosexual men, who comfortably parked themselves between 21 and 24 inches from the comely female stranger. The men who declared themselves in "stable, monogamous" relationships and got a dose of the hormone chose to stand, on average, about 6 1/2 inches farther away. When researchers conducted the experiment with a placebo, they found no differences in the distance that attached and unattached men maintained from a woman they had just met. Even when an attractive woman was portrayed only in a photograph, the monogamous men who received oxytocin put a bit more distance between themselves and her likeness. But when the new acquaintance was a man, administration of oxytocin did not prompt attached men to stand farther away than single men, the researchers reported. Los Angeles Times, Copyright 2012
by Andy Coghlan Men with partners increase the space they feel comfortable with between themselves and an attractive woman if exposed to the bonding hormone oxytocin. René Hurlemann at the University of Bonn in Germany and colleagues gave men either a sniff of oxytocin or a placebo before asking them to choose the ideal distance for an interaction with a woman. The distance that they felt was comfortable significantly increased after sniffing oxytocin, but only for men in relationships. The team conclude that oxytocin discourages partnered but not single men from getting close to a female stranger. Journal reference: Journal of Neuroscience, DOI: 10.1523/jneurosci.2755-12.2012 © Copyright Reed Business Information Ltd.
by Shaoni Bhattacharya Talk about having your cake and eating it. Fasting might not be the only route to a longer life – a hormone seems to work just as well, for mice at least. We know that some animals can extend their lifespan by consuming fewer calories. Engineered mice can get the same effect by simply pumping out high levels of a hormone normally produced during a fast, according to Steven Kliewer and David Mangelsdorf at the University of Texas Southwestern Medical Center in Dallas. Their team found that mice engineered to make higher levels of the hormone, FGF21, increased their lifespan on average by over a third. "What we are seeing is the benefit of caloric restriction without having to diet," he says. Humans have the hormone too, and Kliewer believes FGF21 has the potential to extend the human "health-span" – the time we live healthy lives. The researchers believe FGF21 may act to prolong life by affecting pathways such as the insulin-like growth factor-1 (IGF-1) pathway implicated in ageing. "It blocks growth hormones promoting pathways which are associated with diseases, including cancers and metabolic diseases, and as a consequence these animals live longer," says Kliewer. © Copyright Reed Business Information Ltd.
Researchers in the U.S. have found signs of puberty in American boys up to two years earlier than previously reported — age nine on average for blacks, 10 for whites and Hispanics. Other studies have suggested that girls, too, are entering puberty younger. Why is this happening? Theories range from higher levels of obesity and inactivity to chemicals in food and water, all of which might interfere with normal hormone production. But those are just theories, and they remain unproven. Doctors say earlier puberty is not necessarily cause for concern. And some experts question whether the trend is even real. Boys are more likely than girls to have an underlying physical cause for early puberty.Boys are more likely than girls to have an underlying physical cause for early puberty. (Jennifer DeMonte/Associated Press) Dr. William Adelman, an adolescent medicine specialist in the Baltimore area, says the new research is the first to find early, strong physical evidence that boys are maturing earlier. But he added that the study still isn't proof and said it raises a lot of questions. Earlier research based on 20-year-old national data also suggested a trend toward early puberty in boys, but it was based on less rigorous information. The new study involved testes measurements in more than 4,000 boys. Enlargement of testes is generally the earliest sign of puberty in boys. The study was published online Saturday in Pediatrics to coincide with the American Academy of Pediatrics' national conference in New Orleans. © CBC 2012
By Marcia Malory Ask this question, and you will probably receive one of two responses: Yes. People choose to be gay. They are making an immoral choice, which government should discourage. Or No. Sexual preference is biologically determined. Government should protect gay people from discrimination because homosexuality is an unalterable aspect of their identity. These two answers have something in common: With both of them, the science conveniently supports the moral decision. What if neither answer is right? Perhaps sexual preference can be changed – and people have the right to engage in gay sex and have homosexual relationships if they choose to do so. (The fourth option, that gay people have no choice but to be gay, but should be punished for it anyway, is morally unthinkable.) What does science tell us about sexual preference? We know, from many twin and adoption studies, that sexual preference has a genetic component. A gay man is more likely than a straight man to have a (biological) gay brother; lesbians are more likely than straight women to have gay sisters. In 1993, a study published in the journal Science showed that families with two homosexual brothers were very likely to have certain genetic markers on a region of the X chromosome known as Xq28. This led to media headlines about the possibility of the existence of a “gay gene” and discussions about the ethics of aborting a “gay” fetus. © 2012 Scientific American,
By Tina Hesman Saey New work suggests that a hormone that makes the body think it’s starving could prolong life about as long as severely cutting calories does but without the denial. A hormone called fibroblast growth factor-21, or FGF21, lengthened the lives of mice that had been genetically engineered to constantly produce large amounts of the protein, researchers at the University of Texas Southwestern Medical Center at Dallas report online October 15 in eLife. The hormone is normally made by the liver during fasting and may tap into some of the same life-extending biochemical processes as does caloric restriction, a proven longevity booster. Caloric restriction — usually defined as cutting calorie intake to 75 to 80 percent of the amount needed to maintain normal body weight, while still maintaining good nutrition — has been shown lengthen life in a wide variety of species, such as fruit flies and dogs. Minimal calorie consumption turns on many different biological processes that slow aging, says Cynthia Kenyon, a developmental biologist at the University of California, San Francisco. The hormone in the study somehow interferes with a chain reaction anchored by insulin-like growth factor-1 (IGF-1), a process that is also shut down by caloric restriction and thought to be responsible for many of its life-extending effects. In the study, researchers led by UT Southwestern’s David Mangelsdorf and Steven Kliewer genetically engineered mice to constantly make five to 10 times as much FGF21 as normal. These engineered mice lived 30 to 40 percent longer than normal mice on a standard diet. Female mice benefitted from the hormone even more than males; about a third of the FGF21-producing female mice still were alive at 44 months old. Average survival for normal mice in the study was about 28 months. © Society for Science & the Public 2000 - 2012
By Gary Stix First off, this study on a molecule tied to social interaction was conducted in animals. So I’m supposed to turn on the siren and the flashing red light here to let you know that the headline you just read might not apply in humans. Still, the animals in question, prairie voles, are a special case, models of faithfulness that put humans to shame when it comes to the delicate topic of monogamy. Once hitched, the rodents stick with their mates for life—an example of moral pulchritude in the animal kingdom that many of us human sinners can never hope to emulate. It could easily become the state animal for whole regions of the U.S. For just that alone, the implications of the experiment in question are particularly intriguing. The new research shows that oxytocin, the bonding hormone, is sometimes capable of turning the upstanding rodent into an anti-social lout, making the study results more compelling in many ways than if they were reported in errant humans. So the man-bites-dog headline stays. This all came up when Karen Bales, a professor at University of California, Davis, wanted to know what would happen if oxytocin gets administered for lengthy intervals, not the short-term dosing that has occurred in the multitude of previous vole studies that linked the hormone to monogamous behavior. In their experiment, Bales and team gave either a low, medium or high dose through the nose to 29 voles, and a saline solution to 14 controls At first, the animals became all cuddly as in previous studies But after three weeks, an entire vole childhood (from weaning to sexual maturity), they started breaking bad. Males did not engage in the normal behavior of “pair bonding,” that drives them to look for the girl of their dreams. And female voles’ natural mothering instinct seemed to disappear: when placed nearby young pups that were not their own, they didn’t dote, as they are wont to do. The cuddle hormone had turned the rodents into meanies. © 2012 Scientific American
(Relaxnews)—In a study of more than 90 men, scientists from the University of Bonn, Germany, found that subjects treated with a dose of testosterone before the study told fewer lies than those who received a placebo. "Testosterone has always been said to promote aggressive and risky behavior and posturing," says researcher and neuroscientist Bernard Weber. However, more recent studies indicate that it also fosters social behavior. Prior research has suggested that the hormone may actually cause people to be more "prosocial" in that they voluntarily act in the interest of others, writes the Atlantic magazine, but exactly how the hormone influences behaviors isn't understood. For this latest study, 46 subjects were treated with testosterone by applying it to the skin in gel form, while 45 subjects received a placebo. The next day, the subjects played a dice game in which it was easy for the men to lie to earn more money, with no possibility of being caught. The study was designed so that it was impossible even for the researchers to detect whether a subject was lying or not. Rather, they used statistics to analyze reported earnings that were higher than probability would allow, inferring from these how honest the subjects were being. While many people in the study lied about the game, there was a noticeable difference between the men boosted with testosterone and those who weren't—the testosterone group avoided the temptation to cheat more often. Blood tests confirmed the results that high testosterone levels were linked with more honest game playing. "Test subjects with the higher testosterone levels had clearly lied less frequently than untreated test subjects," says co-author Armin Falk. "This result clearly contradicts the one-dimensional approach that testosterone results in anti-social behavior." The study was published last week in the journal PLoS One . http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0046774 © 2012 NY Times Co.
Keyword: Hormones & Behavior
Link ID: 17378 - Posted: 10.17.2012
Cort Pedersen at the University of North Carolina at Chapel Hill and his team gave 11 alcohol-dependent volunteers two daily doses of an oxytocin nasal spray or a placebo, during the first three days of a detox programme. The volunteers also received lorazepam - a detox drug - when their withdrawal symptoms reached a specific level. The oxytocin group had fewer alcohol cravings and milder withdrawal symptoms than the placebo group, and used just one-fifth of the lorazepam (Alcoholism: Clinical and Experimental Research, doi.org/jgp). "Four [oxytocin] volunteers didn't need any lorazepam at all," says Pedersen. This is good news because lorazepam is highly addictive. While it reduces anxiety and seizures during alcohol withdrawal, users can experience insomnia and cravings when they come off the drug. Although it is unclear how oxytocin - famed for its role in social bondingMovie Camera - helps to aid withdrawal, it has no known side effects. Pedersen hopes that alcoholics who take the hormone will therefore be less likely to experience the unpleasant symptoms that can lead to relapse. © Copyright Reed Business Information Ltd.
by Gisela Telis In the industrialized world, women live at least 5 years longer, on average, than men. Scientists have attributed that difference to everything from healthier habits to hardier cells. Now, a new study that analyzes the longevity of eunuchs, or castrated men, suggests that testosterone may play a part in shortening men's lives. The idea that testosterone, the male sex hormone, affects lifespan isn't new. Neutered dogs and other animals that have had their sources of testosterone removed often live longer than their intact counterparts. But studies on the connection between castration and longevity in humans are harder to come by, and the results have been inconclusive. A 1969 study of institutionalized patients in Kansas found that castrated men lived an average of 14 years longer than other men in the same facility, but a 1993 study of Italian castrati (singers castrated as boys to preserve their high voices) found nothing unusual about their longevity. Almost 5 years ago, biologist Kyung-Jin Min of Inha University in Incheon, Korea, found himself considering this lack of data while watching a Korean TV drama about eunuchs. Min began to wonder if Korea's rich historical records could shed light on the link between castration and longevity in humans. Until the late 19th century, Korean rulers employed eunuchs to serve the royal court. These eunuchs were allowed to marry and adopt castrated boys as their sons. The Yang-Se-Gye-Bo, a genealogical record of the eunuch families, has survived, and it documents the birth and death dates and other personal details of 385 eunuchs who lived between the mid-16th century and the mid-19th century. © 2010 American Association for the Advancement of Science.
By Judy Stone In one sense, it is refreshing to see men being the target of pharma, after all these years of women being the focus of relentless—and misleading—advertising. On the other, we’re seeing the start of yet another pharma campaign to dupe the public by the unnecessary medicalization of symptoms to create new drug markets. I used to be a fairly enthusiastic pharma fan, but over recent years have become increasingly disillusioned. The hype over testosterone is the latest example of why. With so many pressing problems in the world, I wish pharma would focus their attention on doing something more useful with their energies. I thought it started with drugs for “hot flashes,” but Karen Roush set me straight about hormone therapy, reporting that “It all started with men in ancient civilizations eating the penis and testicles of animals as a cure for impotence.” (And to think that Maryn McKenna just warned us of the dangers of kissing cats! This early hormone therapy sounds a bit dicier.) In the 1940s, estrogen was able to be extracted from horse urine in large quantities, enabling a supply for treating women “suffering from estrogen deficiency.” Dr. Robert Wilson, a prominent New York gynecologist, founded a private trust in 1963 to promote estrogen use. Pharmaceutical companies provided $1.3 million to this “trust;” they, of course, stood to profit handsomely from their investment in Wilson’s endeavor. Wilson is described as being “evangelical” in his crusade to save women from the “decay” of menopause. He was quite successful, with his 1966 book, Feminine Forever, selling 100,000 copies in the first seven months alone. His theme, “A Plea for the Maintenance of Adequate Estrogen from Puberty to Grave,” expounded in a mainstream medical journal, was adopted both by the medical profession and by the popular press. © 2012 Scientific American
By GRETCHEN REYNOLDS It’s widely accepted among scientists that regular exercise transforms the brain, improving the ability to remember and think. And a growing and very appealing body of science has established that exercise spurs the creation of new brain cells, a process known as neurogenesis. But just how jogging or other workouts affect the structure of the brain has remained enigmatic, with many steps in the process unexplained. A new study published last month in Proceedings of the National Academy of Sciences may fill in one piece of the puzzle, by showing that male sex hormones surge in the brain after exercise and could be helping to remodel the mind. The research was conducted on young, healthy and exclusively male rats – but scientists believe it applies to female rats, too, as well as other mammals, including humans. The decision to use only males was carefully considered. “We’ve known for a while that estrogen,” the female sex hormone, “is produced in the brain” not just of female animals but also, to some degree, in males, says Bruce S. McEwen, the director of the Laboratory of Neuroendocrinology at Rockefeller University in New York and an author of the study, which also involved scientists from the University of Tsukuba in Japan and other institutions. Estrogen has been well studied and has many effects, he said, including, scientists suspect, new brain cell growth. But far less has been known about the role of male sex hormones in mammalian brains, particularly after exercise. While both sexes produce male sex hormones, males produce far more of it – mostly in the gonads but, the researchers suspected, also in the brain. Copyright 2012 The New York Times Company
By Matthew Perrone, Associated Press "Do you have a decrease in libido?" "Have you noticed a recent deterioration in your ability to play sports?" "It could be Low-T." Welcome to the latest big marketing push by the nation's drug companies. In this case, it's a web page for Abbott Laboratories' Androgel, a billion-dollar selling testosterone gel used by millions of American men struggling with the symptoms of growing older that are associated with low testosterone, such as poor sex drive, weight gain and fatigue. Androgel is one of a growing number of prescription gels, patches and injections aimed at boosting the male hormone that begins to decline after about age 40. Drugmakers and some doctors claim testosterone therapy can reverse some of the signs of aging — even though the safety and effectiveness of such treatments is unclear. "The problem is that we don't have any evidence that prescribing testosterone to older men with relatively low testosterone levels does any good," says Dr. Sergei Romashkan, who oversees clinical trials for the National Institute on Aging, a part of the National Institutes of Health conglomerate of research centers. Low testosterone is the latest example of a once-natural part of getting old that has become a target for medical treatment. Bladder problems, brittle bones and hot flashes have followed a similar path: from inconvenient facts of life, to ailments that can be treated with drugs. The rise of such therapies is being fueled by both demographics and industry marketing. © 2012 NBCNews.com
By Scicurious We’ve all heard of the legendary monogamous prairie vole, haven’t we? Our adorable rodent friend forms the kind of attachments that make us humans feel slightly ashamed of our more promiscuous habits. And of course, if we know about prairie voles, we know about oxytocin (and I’ve got a whole series on it over at the ‘Science! 101′ page of my other site). Prairie voles are monogamous primarily due to the actions of oxytocin in the female, and vasopressin in the male. Without these two hormones, the prairie voles will love ‘em and leave ‘em just like their close cousins, the meadow vole. But is that all there really is to pair bonding? Just one hormone, a desire to stay with your furry mate forever…and that’s it? No, it’s more complicated than that. There are two real aspects to a pair bond. The first is the prosocial bit, the animal preferring to associate with one particular other animal. In voles, this requires the hormones oxytocin and vasopressin, and the neurotransmitter dopamine. But there’s another aspect to pair bonding: maintenance. And that requires more than fuzzy feelings, it also requires rejection of other potential mates, and guarding your mate against all comers. This aggressive behavior also involves dopamine, but in this case, a different population of receptors. © 2012 Scientific American
By Daisy Yuhas How do I love thee? When neuroscientist Young and journalist Alexander started counting, they found many molecular ways. In The Chemistry between Us, the writers highlight the complex chemical processes that create love in the brain and bolster the argument that love is an addiction. Young has devoted his career to studying the behaviors and neural circuitry of love in the prairie vole, a rodent whose monogamous tendencies resemble our own. Once a prairie vole has found “the one,” the pair will most likely remain companions for life. Young's research has implicated a range of chemical activities—mainly during sex—that build this lifelong bond. In particular, he uncovered how two hormones in the brain, vasopressin in male voles and oxytocin in female voles, regulate social behavior and memory—promoting the recognition of a loved one and the urge to cuddle or defend. In addition, the circulation of dopamine and opioids allows the vole to associate his or her partner with pleasure, thus strengthening their bond. Many of these molecules are identical to those activated in human bonding. That loving feeling comes at a price. A hormone called corticotropin-releasing factor, or CRF, builds up in the brains of paramours and parents alike. The CRF system activates a stress response, and this system elicits the painful sensations you feel when your baby cries or your boyfriend dumps you. The system may seem like a nasty trick, but it has its uses. Even when passion fades or a diaper needs changing, the sharp pangs of the CRF system keep families and loved ones together. The CRF system also contributes to the agony an addict feels after the elation wears off. Thus, the authors argue, the highs of intimacy and withdrawals of separation parallel the highs and lows that drug addicts experience. © 2012 Scientific American
by Sara Reardon Freedom of information requests have revealed that pregnant women may not have been given all the facts before taking an experimental treatment to prevent female fetuses from being masculinised as a result of a rare genetic disorder. Research has provided some evidence that dexamethasone, a drug normally prescribed to relieve inflammation, can prevent girls with a rare hormonal disease from developing male genitalia and same-sex attraction if they are treated as fetuses. But as yet, no clinical studies show that this treatment is safe, says Alice Dreger of Northwestern University in Evanston, Illinois. She claims that researchers have misled an unknown number of pregnant women into taking the experimental treatment without properly informing them of its risks. Since the 1980s, Maria New of Mount Sinai School of Medicine in New York has studied and popularised the idea of prescribing dexamethasone "off-label" to women at risk of having foetuses with congenital adrenal hyperplasia (CAH). The treatment is now taught as standard practice in medical schools. But because the drug must be given very early in pregnancy before the fetus' gender or CAH status is known, many fetuses are treated unnecessarily. A child with two carrier parents has a one-in-four chance of having the disease, and the treatment only works for girls. There is little research available on the effects of dexamethasone, which mimics a steroid hormone. And because dexamethasone doesn't cure CAH but only prevents masculinisation of girls, it can be difficult to distinguish possible effects of the drug from other treatments the children receive after birth. © Copyright Reed Business Information Ltd.
By Susan Milius OTTAWA — Some of the animal kingdom’s showiest extremes, from deer antlers to the outsized horn of the male rhinoceros beetle, may be natural insulin meters. As an animal grows, the nubbins of tissue that will form its big weapons or displays may be more sensitive to insulin than other developing body parts, Douglas Emlen of the University Montana said July 10 at the Evolution Ottawa scientific congress. The proposal “potentially narrows the range of explanations for the evolution of ornaments and weapons,” said Bob Montgomerie of Queen’s University in Kingston, Ontario, who studies courtship-related features in birds. Insulin orchestrates growth in tune with how much food a young animal gets, Emlen explained. A well-fed youngster flush with insulin will grow the most spectacular horns or other paraphernalia, while underfed rivals remain stunted. If the growing antlers or other extreme structures are supersensitive to insulin, they will supersize out of proportion to less sensitive tissue. That’s the case for the horns of the rhinoceros beetle, Trypoxylus dichotomus. Males of the species grow horns about two-thirds as long as the rest of their bodies. They use these fearsome weapons to knock rivals away from sap-oozing wounds on trees where females go to feed. The horns are eight times more responsive to insulin or insulin-like growth factors than some other body parts, Emlen said. That sensitivity fits with reports from other researchers that insulin or related signals affect development of antlers in red deer and the outsized male claws in a type of shrimp and one kind of crab. For those animals though, researchers haven’t yet explored how the weaponry tissues’ sensitivity compares with that of other body parts. © Society for Science & the Public 2000 - 2012
By Helen Shen, Globe Correspondent The International Olympic Committee has issued new rules for the 2012 London Games that would require checking testosterone levels in athletes whose eligibility as females is called into question. Several elite female athletes have previously been accused of secretly being males, including South African runner Caster Semenya , who was investigated and later cleared after her 2009 world championship victory in the 800-meter event drew accusations from competitors. The IOC says its intent is to identify athletes who would be ineligible “by reason of hormonal characteristics” -- not to determine gender, but the policy has drawn criticism. Stanford University bioethicist Katrina Karkazis said the inclusion of a gynecologist and geneticist on the IOC examining panel contradicts this message. “It’s way more than a blood test or a series of blood tests. There will be genital exams, there will be genetic testing,” she said. Athletes will be disqualified to compete as females if they are found with testosterone levels typical of males, and if they possess cellular receptors that respond to the hormone’s effects, which include boosting muscle mass and strength. “They chose something that really does discriminate between males and females,” said Dr. Joshua Safer, an endocrinologist at Boston Medical Center and expert in transgender care. Testosterone levels vary from one individual to another and, for a given individual, can vary widely by time of day. But the overall ranges of testosterone are about 10 times higher in men than in women, he said. © 2012 NY Times Co.
By Nathan Seppa HOUSTON — Men with low testosterone who are given replacement doses of the hormone shed weight steadily for years, researchers in Germany reported June 23 at a meeting of the Endocrine Society. Study participants, nearly all of whom were overweight or obese at the start of the study, lost 36 pounds on average. “This was an unintended effect,” said study coauthor Farid Saad, a research endocrinologist at Bayer Pharma in Berlin. “The big surprise was that when we analyzed the data [we found] that these men had lost weight continuously...year by year.” The men didn’t diet as part of the study, and any increase in their activity was voluntary, Saad said. He and his colleagues studied 116 men, average age 61, who had low testosterone levels. Each received quarterly injections of the hormone for five years. At the start, 71 percent were obese and another 24 percent were overweight. After five years, 97 percent of the men showed a reduction in waist circumference, on average losing “three to four trouser sizes,” Saad said. Average weight dropped from 236 pounds to about 200. “This definitely offers some insight that we can apply to our clinical practices,” said Vineeth Mohan, a clinical endocrinologist at Cleveland Clinic Florida in Weston. High testosterone levels have been linked to prostate cancer risk (SN: 10/8/05, p. 238), and a small portion of men taking high doses of it experience mania (SN: 2/19/00, p. 119). But in this study, Saad said, men received testosterone in doses just high enough to bring them back to normal levels. Three men in the test group were diagnosed with prostate cancer during the study, a rate lower than the incidence found in routine screening programs for men that age, he said. © Society for Science & the Public 2000 - 2012